论文信息 - SRSF2 is Mutated in 47.2% (77/163) of Chronic Myelomonocytic Leukemia (CMML) and Prognostically Favorable in Cases with Concomitant RUNX1 mutations - 字舞流文

SRSF2 is Mutated in 47.2% (77/163) of Chronic Myelomonocytic Leukemia (CMML) and Prognostically Favorable in Cases with Concomitant RUNX1 mutations

S. Ogawa | A. Kohlmann | T. Haferlach | S. Schnittger | W. Kern | Kenichi Yoshida | C. Haferlach | H. Koeffler | M. Meggendorfer | V. Grossmann